Salix Pharmaceuticals Ltd.

May 17, 2019

Salix Pharmaceuticals Pledges Annual $100,000 Scholarship Program To Outstanding Students Living with GI Disease

Sep 06, 2018

Salix Pharmaceuticals To Present Clinical Data For The Treatment Of Opioid-Induced Constipation At 2018 PAINWeek Conference

Jun 05, 2018

Salix And Its Partner Norgine Present New Data From PLENVU® (NER1006) Phase 3 Studies At Digestive Disease Week (DDW) 2018

Jun 03, 2018

Salix Presents Rifaximin Phase 3 Study Results for Irritable Bowel Syndrome with Diarrhea at Digestive Disease Week

May 07, 2018

Salix Receives FDA Approval For PLENVU®, Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies

Apr 03, 2018

Salix Launches 'Let's Talk 2' IBS Awareness Campaign

Feb 09, 2018

Salix Provides Update on FDA Submission for PLENVU®*

Sep 05, 2017

Salix Announces Four Poster Presentations, Two Product Theatres At PAINWeek 2017

Jun 28, 2017

Salix Announces Filing Acceptance for PLENVU®* Next Generation Bowel Cleansing Preparation for Colonoscopies